gyki 52466 has been researched along with Lung Neoplasms in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we report that the AMPA antagonists GYKI 52466 and CFM-2 inhibit the extracellular signal regulated kinase (ERK1/2) pathway, an intracellular signaling cascade which is activated by growth factors and controls proliferation of lung adenocarcinoma cells." | 3.74 | AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth. ( Brocke, K; Gratopp, A; Ikonomidou, C; Pohl, EE; Rzeski, W; Sifringer, M; Stepulak, A; Turski, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stepulak, A | 1 |
| Sifringer, M | 1 |
| Rzeski, W | 1 |
| Brocke, K | 1 |
| Gratopp, A | 1 |
| Pohl, EE | 1 |
| Turski, L | 1 |
| Ikonomidou, C | 1 |
1 other study available for gyki 52466 and Lung Neoplasms
| Article | Year |
|---|---|
AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth.
Topics: Adenocarcinoma; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antineoplastic Agents; Ben | 2007 |